IPO
LivsMed Inc.
리브스메드
Stock page →What the company does
Reves Med develops, manufactures and sells laparoscopic surgical instruments for minimally invasive surgery. Its main products include the ArtiSential multi-joint laparoscopic instrument and the ArtiSeal vascular stapler, both with 90-degree articulation.
- Market
- KOSDAQ
- Price range
- ₩44,000 – ₩55,000
- Offer price
- ₩55,000
- Subscription
- Dec 15 – Dec 16
- Payment date
- Dec 18, 2025
- Listing
- Dec 24, 2025
- Shares offered
- 2,470,000
- Raising
- ₩108.7B
- First day
- ▼ -9.8% ₩49,600
- First close vs the offer price
Lead managers: Samsung Securities, Mirae Asset Securities
Filings
- [기재정정]투자설명서Dec 12, 2025Open on DART ↗
- [발행조건확정]증권신고서(지분증권)Dec 12, 2025Open on DART ↗
- 투자설명서Dec 10, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Dec 5, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Nov 24, 2025Open on DART ↗
- [첨부정정]증권신고서(지분증권)Nov 18, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Nov 18, 2025Open on DART ↗
- [기재정정]증권신고서(지분증권)Nov 4, 2025Open on DART ↗
- [첨부추가]증권신고서(지분증권)Oct 20, 2025Open on DART ↗
How a Korean IPO works: institutions bid first (the demand forecast), which sets the final offer price; then individuals subscribe for two days through the lead managers' brokerage accounts; shares start trading on the listing date.
Dates and prices can change until the final terms are filed. Not financial advice. · Updated Oct 17, 2026 · IPO calendar